Previous Page  15 / 50 Next Page
Information
Show Menu
Previous Page 15 / 50 Next Page
Page Background

Pharmacognosy 2018

American Journal of Ethnomedicine

ISSN: 2348-9502

Page 75

April 16-17, 2018

Amsterdam, Netherlands

6

th

Edition of International Conference on

Pharmacognosy and

Medicinal Plants

Perspectives on dermatological and cosmeceutical properties

of compound K

En Hyung Kim

Dankook University, South Korea

G

insenosides are representative pharmaceutical compounds

found in various forms in Panax ginseng, a traditional

medicinal plant. There have been many reports describing the

biological activities, including anti-inflammatory, anti-tumor, and

anti-dementia effects, of several ginsenosides. The biological

actions of these ginsenosides have been closely related to their

biotransformations by intestinal microbiome. They are converted

to their metabolites Rg2, Rg3, compound K, and others by human

intestinal microflora following ingestion. The main functional

component detected in mammalian blood or organs after oral

administration of ginseng or ginsenosides is compound K.

Compound K has been reported to exhibit diverse biological

functions, including antitumor, antidiabetic, antiallergic, and

anti-inflammatory effects

in vitro

and

in vivo

. Recently, antiaging

effects of ginsenosides in human skin have been reported from

clinical trial and

in vitro

model data. Ginsenosides have hence

been proposed as promising natural cosmeceutical agents. We

reviewed the biotransformation and delivery of compound K.

Also biological effects of ginsenosides, especially compound K,

on skin health and its potential use as cosmeceutical agents was

studied.

Recent Publications

1. Kim E H (2017) Pruritic urticarial papules and plaques

of pregnancy occurring postpartum treated with

intramuscular injection of autologous whole blood. Case

Rep Dermatol. 9(1):151–156.

2. Kim E H (2017) A case of facial partial unilateral

lentiginosis treated with low-fluence 1,064 nm

Q-switched neodymium-doped yttrium aluminum garnet

laser. Case Rep Dermatol. 9(2):30–34.

3. Kim E H, Park M J, Park S and Lee E S (2015) Increased

expression of the NLRP3 inflammasome components

in patients with Behçet’s disease. J Inflamm (Lond).

2(12):41.

4. Nam S W, Ko S Y, Lee Y K, Shin S M and Kim E H (2014)

The incidence of birthmarks in Korean newborn infants.

Neonatal Med. 21(3):151–157.

5. Lee J Y, Park J Y, Kim E H, Tak M J and Lee E S

(2012) Simultaneous involvement of nervous and

gastrointestinal systems in Behçet’s disease. Ann

Dermatol. 24(2):225.

Biography

En Hyung Kim finished her residency in Dermatology at Ajou University

Hospital and is currently the Director of Department of Dermatology at Cheil

General Hospital and Women’s Healthcare Center. As a Scientist, she is in-

terested in Skin Physiology and Inflammatory Mechanisms. As a Clinician,

shemakes effort to find new innovative ways to treat her patients effectively

and safely.

imehk77@gmail.com

En Hyung Kim, Am J Ethnomed 2018, Volume 5

DOI: 10.21767/2348-9502-C1-006